A Study Comparing Surovatamig Plus Rituximab With Standard Treatment in People With Follicular Lymphoma

Full Title

A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 plus Rituximab versus Chemotherapy plus Rituximab in Previously Untreated Participants with Follicular Lymphoma (SOUNDTRACK-F1)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Lorenzo Falchi’s office at 646-608-3705.

Protocol
26-352
Phase
Phase III (phase 3)
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT06549595